Predictors of Androgen Status Decline in Middle-Aged Men
Recruiting
Observational Study
Testosterone Deficiency
Androgen Deficiency
Male Hypogonadism
Late-Onset Hypogonadism
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 35 – 59
- Sex
- Male
- Study type
- Observational
- Participants needed
- 600 (estimated)
- Sponsor
- Andijan State Medical Institute · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Decreased testosterone levels in middle-aged men are associated with multiple metabolic, functional and psychosocial consequences. Early identification of modifiable factors associated with reduced testosterone levels may facilitate the early identification of men at increased risk of testosterone deficiency and support preventive healthcare strategies.
This population-based cross-sectional obser…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Men aged 35-59 years
* Permanent residence in the Andijan region of Uzbekistan
* Ability and willingness to provide written informed consent
* Willingness to undergo clinical, anthropometric, functional and laboratory assessments
Exclusion Criteria:
* Previously diagnosed hy…
Contacts